BioCentury
ARTICLE | Company News

Glycobiosciences Inc., Hi-Tech Pharmacal sales and marketing update

January 23, 2012 8:00 AM UTC

Glycobiosciences granted Hi-Tech exclusive, U.S. commercialization rights to a hyaluronic acid and emollient-based topical wound gel. Hi-Tech will immediately launch the gel, which has 510(k) clearanc...